These side effects were notably milder in comparison to an inhibitor of the two bromodomains. A detailed molecular analysis also revealed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor 88 These preclinical studies deliver paradigms for long run clinical trials in AML, and using https://lloydl665wht8.wikilinksnews.com/user